Sugi Predict

Sugi Predict / Compounds / SCHEMBL218710

SCHEMBL218710

SCHEMBL218710

CC(C)(C)[Si](C)(C)OCc1ccc(-c2ccc3nc(-c4ccc5cc[nH]c5c4)cn3c2)o1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 2/20 0.37
▸ KDM4E B2RXH2 9/20 0.35
▸ RAB9A P51151 9/20 0.35
▸ NPC1 O15118 9/20 0.35
▸ MAPT P10636 6/20 0.35
▸ PKM P14618 3/20 0.35
▸ SYK P43405 1/20 0.34
▸ ALDH1A3 P47895 5/20 0.33
▸ ALDH1A1 P00352 7/20 0.33
▸ SMN1; SMN2 Q16637 5/20 0.33
▸ HPGD P15428 3/20 0.33
▸ NFKB1 P19838 2/20 0.33
▸ NFKB2 Q00653 2/20 0.33
▸ RELA Q04206 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL220288 0.82 ADORA2A (0.40) ADORA2AKDM4ERAB9ANPC1MAPT
SCHEMBL3433820 0.81 NR4A2 (0.45) ADORA2AALDH1A3ALDH1A1
SCHEMBL219516 0.78 ADORA2A (0.32) ADORA2AALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL218709 0.77 ADORA2A (0.37) ADORA2AKDM4ERAB9ANPC1MAPT
SCHEMBL219538 0.74 ADORA2A (0.40) ADORA2AKDM4ERAB9ANPC1MAPT
SCHEMBL3431818 0.69 NR4A2 (0.49) ALDH1A3ALDH1A1
SCHEMBL220684 0.68 NR4A2 (0.42) KDM4ERAB9ANPC1MAPTPKM
SCHEMBL1607218 0.68 MEN1 (0.41) KDM4EALDH1A1HPGDHSD17B10MAPK1
SCHEMBL3430915 0.68 NR4A2 (0.68) RAB9ANPC1ALDH1A3ALDH1A1HPGD
SCHEMBL218321 0.68 NR4A2 (0.43) KDM4ERAB9ANPC1MAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2262804-B1 POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYL-IMIDAZO[L,2- A] PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2014-12-03 — — EP disclosed
US-8598166-B2 Polysubstituted derivatives of 6-heteroarylimidazo[1,2-a]pyridines, and preparation and therapeutic use thereof SANOFI (FR) 2013-12-03 — — US disclosed
US-20120053202-A1 POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2012-03-01 — — US disclosed
US-8088765-B2 Polysubstituted derivatives of 6-heteroarylimidazo[1,2-a]pyridines, and preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2012-01-03 — — US disclosed
US-20110065700-A1 POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065700-A1 POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF CYP4X1, HAX1, JAK2 ADORA2A 279/4885KDM4E 1360/4885RAB9A 1592/4885
US-20120053202-A1 POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF CYP4X1, HAX1, JAK2 ADORA2A 279/4885KDM4E 1360/4885RAB9A 1592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.